[Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)].
D000179:Acrylates / Q000627:therapeutic use*; D000840:Anisoles / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001966:Bromine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004341:Drug Evaluation; D005706:Gallbladder Neoplasms / Q000188:drug therapy; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007659:Ketones / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D013997:Time Factors
D000179:Acrylates; D000840:Anisoles; D000970:Antineoplastic Agents; D007659:Ketones; D003520:Cyclophosphamide; D001966:Bromine
Cytembena a cyclophosphamid v lécbĕ pokrocilých neoplazií zazívacího ústrojí.